With the midyear mark rapidly approaching, this might be a good time to consider the current state of long-term care.
Group re-assessing antipsychotic label warning
By
Kristen Fischer
Mar 22, 2024
Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults.
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
Alternatives to antipsychotics can create new dangers, study finds
By
Alicia Lasek (f3)
Jun 01, 2022
Fewer residents with dementia now receive off-label antipsychotic drugs in VA nursing facilities. But overreliance on other behavior-modifying medications has spiked, a new study finds.
The importance of informed consent in antipsychotic regulations
By
Karen Robson
Mar 16, 2022
Informed consent is not consistently interpreted in regards to the use of drugs such as antipsychotics in nursing home residents with dementia.
Antipsychotic medication reduction and the severely mentally ill population
By
Eleanor Feldman Barbera, Ph.D.
Mar 08, 2022
President Biden’s State of the Union address last week targeted several aspects of the long-term care industry, most of which have received more attention than his mention of reducing the inappropriate...
As antipsychotic use appears to backslide among nursing home residents, risks mount
By
Kimberly Marselas
Oct 11, 2021
For more than a decade, patient advocates and federal regulators have called for a reduction in nursing homes’ use of antipsychotic medications, a class of drugs once widely associated with controlling...
Nursing homes, feds hide sky-high antipsychotic use with dubious diagnoses: report
By
Alicia Lasek
Sep 20, 2021
At least one-fifth of nursing home residents are taking the drugs, many for schizophrenia, a diagnosis that has skyrocketed in these settings since 2012, a new investigation finds.
Industry balks at drug report
By
Elizabeth Newman
Mar 08, 2018
Skilled nursing leaders criticized a Human Rights Watch report on antipsychotics in February.
Nursing homes receive an unexpected compliment
By
James M. Berklan
Mar 09, 2015
Would anyone recommend duplicating something if they didn’t feel it was worthy or successful? Of course not. It’s this reasoning that should give skilled nursing operators comfort and pride.